Mayo Clinic researchers combined the results of a functional test that measures the effect of inherited variants in the BRCA2 gene in breast and ovarian cancer with clinical information from women undergoing genetic testing to determine clinical significance for BRCA2. of many Variants of Unknown Meaning (VUS).
Read more
–
